NATIONAL INSTITUTES OF HEALTH has floated a tender for Seamless Early-Stage Clinical Drug Development (Phase 1 to 2A) for Novel Therapeutic Agents for the Spectrum of Alzheimer's Disease (Ad) and Ad-Related Dementias (Adrd) (Ug3/Uh3 Clinical Trial Require.... The project location is USA and the tender is closing on 19 Nov 2026. The tender notice number is -, while the TOT Ref Number is 87730876.
Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : USA
Summary : Seamless Early-Stage Clinical Drug Development (Phase 1 to 2A) for Novel Therapeutic Agents for the Spectrum of Alzheimer's Disease (Ad) and Ad-Related Dementias (Adrd) (Ug3/Uh3 Clinical Trial Require...
Sign in with Google